Prostate Cancer Clinical Trials in Cleveland

Showing 141-160 of 189 trials

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

NCT00772317

For the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT)

SonaCare Medical117 participantsStarted Jul 2008

Los Angeles, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +13 more locations

TERMINATEDPHASE2< 1 mile

Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

NCT00526591

RATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving everolimus before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This randomized phase II trial is studying the side effects and how well everolimus works in treating patients with newly diagnosed localized prostate cancer.

Prostate Cancer

Jorge A. Garcia, MD17 participantsStarted Sep 2007

Cleveland, Ohio, United States

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

Prostate Cancer Trials in Other Cities

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

Health-Related Quality of Life in Gay Men With Localized Prostate Cancer

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

An Open-label Extension Study of PSMA ADC 2301 in mCRPC

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Vidaza to Restore Hormone Thx Prostate

CHESS: Human and Computer Mentors for Prostate Cancer Patients

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer

Other Conditions in Cleveland